Plain-English translation of NCT04743479 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →This research study is testing a new artificial intelligence system designed to catch pancreatic cancer early in people who have a higher risk of developing it. Researchers will use advanced imaging scans (MRI and CT), blood tests, and an AI-based analysis system to look for signs of pancreatic cancer or pre-cancerous changes. By catching the disease earlier, doctors hope to improve treatment outcomes for people at risk.
Pancreatic cancer is often found too late for effective treatment. This study exists to develop better ways to detect pancreatic cancer in its earliest, most treatable stages—especially in people with known risk factors like diabetes, family history of the disease, or inherited genetic conditions.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will visit the hospital once a year for checkups. At each visit, you'll have blood tests drawn, undergo high-resolution imaging scans (MRI or CT) of your pancreas, and provide information about your health history. If any suspicious areas are found on your scans, you'll have additional imaging with ultrasound. The study will collect your blood sample for genetic testing to better understand pancreatic cancer risk. The research team will follow you for several years to monitor your health.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China